| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
5.98E3 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
5.98E3 |
Evidence |
|
| HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
5.98E3 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
5.98E3 |
Evidence |
|
| HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
5.98E3 |
Evidence |
|
| VIL2 |
IPI00479359 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
5.97E3 |
Evidence |
|
| VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
STX12 |
STX12: Syntaxin-12 |
5.96E3 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
5.84E3 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
5.75E3 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
5.75E3 |
Evidence |
|
| VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
SNAP25 |
SNAP25, SNAP: Synaptosomal-associated protein 25 |
5.70E3 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
5.69E3 |
Evidence |
O
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
5.63E3 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CCNB1 |
Cyclin B1 |
5.63E3 |
Evidence |
|
| WASPIP |
IPI00552369 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
5.62E3 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
5.62E3 |
Evidence |
O
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
5.60E3 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
JUNB |
JUNB: Transcription factor jun-B |
5.60E3 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
PLCB3 |
PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 |
5.59E3 |
Evidence |
|
| CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
5.53E3 |
Evidence |
O
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
JUNB |
JUNB: Transcription factor jun-B |
5.36E3 |
Evidence |
O
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
5.15E3 |
Evidence |
|
| COPE |
COPE: Coatomer subunit epsilon |
COPA |
COPA: Coatomer subunit alpha |
5.15E3 |
Evidence |
O
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
PCAF |
PCAF: Histone acetyltransferase PCAF |
5.10E3 |
Evidence |
|
| ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
5.05E3 |
Evidence |
O
|
